Company: CWAN
Filing Date: 2025-03-06
Form Type: S-4/A
Source: 0001193125-25-048570
Chunk: 213

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-06
Form: S-4/A
Chunk 213
---
, 20% or more of the
consolidated revenues or income or fair market value of the consolidated assets of Enfusion and its subsidiaries, taken as a whole or (y) beneficially own 20% of the voting power of the capital stock of Enfusion (including securities
convertible into or exercisable or exchangeable for equity or voting securities), (iii) any liquidation, dissolution, recapitalization, extraordinary dividend or other significant corporate reorganization of the Enfusion or any of its subsidiaries,
the business of which constitutes 20% or more of the consolidated revenues or income or fair market value of the consolidated assets of Enfusion and its subsidiaries, taken as a whole, (iv) any direct or indirect merger, consolidation, share
exchange, business combination, joint venture, partnership, recapitalization, reorganization or other similar transaction involving Enfusion or any of its subsidiaries, or the surviving entity in such transaction, or resulting direct or indirect
Clearwater entity of Enfusion, any of its subsidiaries or the surviving entity in such transaction, pursuant to which the Enfusion Stockholders immediately preceding such transaction hold less than 80% of the equity interests in the surviving or
resulting entity of such transaction or (v) any combination of the foregoing.

“” means a material
positive fact, event, change, development or circumstance with respect to Enfusion and its subsidiaries or the business of Enfusion and its subsidiaries, taken as a whole, not known, or reasonably foreseeable or expected, by the Special Committee as
of or prior to the date of the Merger Agreement; provided, that in no event will any Effect that results from, involves or relates to any of the following give rise to an Intervening Event: (i) the receipt of an Acquisition Proposal or a
Superior Proposal or any inquiry or communications or matters relating thereto; (ii) the announcement or performance of the Merger Agreement or the pendency or consummation of the Transactions or the other transactions contemplated by the
Merger Agreement; or the identity of Clearwater or any of its affiliates as the acquiror of Enfusion, or any facts or circumstances concerning Clearwater or any of its affiliates, including any communication by any of them regarding plans, proposals
or projections with respect to Enfusion, its subsidiaries or their respective employees; (iii) any change, in and of itself, in the price or trading volume of shares of Enfusion Common Stock (although for purposes of clarity, any underlying
Effect